Donald Trump has abruptly dismissed Attorney General Pam Bondi, citing severe frustrations regarding her handling of highly sensitive federal investigations. The leadership structure at the Department of Justice experienced a profound disruption on Thursday following the sudden termination of the nation’s chief law enforcement officer. President Donald Trump officially dismissed Attorney General Pam Bondi, ending her fourteen-month tenure in a move that underscores the intense political pressure surrounding the executive branch. According to various administrative sources, the dismissal was not the result of a single isolated incident, but rather the culmination of mounting presidential frustration. The executive branch had reportedly…
Author: Kyle Kelley
Pisa-based Wearable Robotics raises €5M Series A to scale its neuromotor rehabilitation exoskeletons and expand clinical deployments across Europe.
NVIDIA pours $2B into Marvell Technology, tightening their NVLink Fusion chip alliance and fortifying its control over next‑gen AI infrastructure against Broadcom’s UALink push.
Enterprise-grade network cabling services are reshaping how organisations manage data, communication and future-ready digital infrastructure.
EquitX rolls out its Testnet, unveiling a synthetic asset protocol built to give traders secure, on-chain exposure to major large-cap markets.
Tenex raises $250M at a $1B+ valuation to expand its AI-managed detection and response platform across major enterprise cloud environments.
A Rivian spinoff focused on urban delivery EVs hits unicorn status after a $200M round led by Greenoaks, targeting the booming last‑mile logistics market.
Whirl AI, founded by ex-Nvidia and Snowflake talent, emerges from stealth with an $8.9M seed round led by ICONIQ to streamline enterprise AI workloads.
OpenAI secures a historic $122B round at an $852B valuation, led by backing from Amazon and NVIDIA, cementing its dominance in the global AI race.
European startup R3 Bio is betting on animal-free, ‘humane’ biotech, with its founding team positioning the company at the intersection of ethics, innovation and scalable therapeutics.